Cargando…

Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease

BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disease, and its pathogenesis is unclear. Previous studies mainly focus on the lesions of substantia nigra (SN) and striatum (Str) in PD. However, lesions are not limited. The olfactory bulb (OB), subventricular zone (SVZ), and hippoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Ying, Huang, Yiying, Shi, Guiying, Lei, Xuepei, Li, Keya, Zhou, Ran, Bai, Lin, Qin, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504527/
https://www.ncbi.nlm.nih.gov/pubmed/34347369
http://dx.doi.org/10.1111/cns.13702
_version_ 1784581336347967488
author Lyu, Ying
Huang, Yiying
Shi, Guiying
Lei, Xuepei
Li, Keya
Zhou, Ran
Bai, Lin
Qin, Chuan
author_facet Lyu, Ying
Huang, Yiying
Shi, Guiying
Lei, Xuepei
Li, Keya
Zhou, Ran
Bai, Lin
Qin, Chuan
author_sort Lyu, Ying
collection PubMed
description BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disease, and its pathogenesis is unclear. Previous studies mainly focus on the lesions of substantia nigra (SN) and striatum (Str) in PD. However, lesions are not limited. The olfactory bulb (OB), subventricular zone (SVZ), and hippocampus (Hippo) are also affected in PD. AIM: To reveal gene expression changes in the five brain regions (OB, SVZ, Str, SN, and Hippo), and to look for potential candidate genes and pathways that may be correlated with the pathogenesis of PD. MATERIALS AND METHODS: We established control group and 6‐hydroxydopamine (6‐OHDA) PD model group, and detected gene expressions in the five brain regions using RNA‐seq and real‐time quantitative polymerase chain reaction (RT‐qPCR). We further analyzed the RNA‐seq data by bioinformatics. RESULTS: We identified differentially expressed genes (DEGs) in all five brain regions. The DEGs were significantly enriched in the “dopaminergic synapse” and “retrograde endocannabinoid signaling,” and Gi/o‐GIRK is the shared cascade in the two pathways. We further identified Ephx2, Fam111a, and Gng2 as the potential candidate genes in the pathogenesis of PD for further studies. CONCLUSION: Our study suggested that gene expressions change in the five brain regions following exposure to 6‐OHDA. The “dopaminergic synapse,” “retrograde endocannabinoid signaling,” and Gi/o‐GIRK may be the key pathways and cascade of the synaptic damage in 6‐OHDA PD rats. Ephx2, Fam111a, and Gng2 may play critical roles in the pathogenesis of PD.
format Online
Article
Text
id pubmed-8504527
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85045272021-10-18 Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease Lyu, Ying Huang, Yiying Shi, Guiying Lei, Xuepei Li, Keya Zhou, Ran Bai, Lin Qin, Chuan CNS Neurosci Ther Original Articles BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disease, and its pathogenesis is unclear. Previous studies mainly focus on the lesions of substantia nigra (SN) and striatum (Str) in PD. However, lesions are not limited. The olfactory bulb (OB), subventricular zone (SVZ), and hippocampus (Hippo) are also affected in PD. AIM: To reveal gene expression changes in the five brain regions (OB, SVZ, Str, SN, and Hippo), and to look for potential candidate genes and pathways that may be correlated with the pathogenesis of PD. MATERIALS AND METHODS: We established control group and 6‐hydroxydopamine (6‐OHDA) PD model group, and detected gene expressions in the five brain regions using RNA‐seq and real‐time quantitative polymerase chain reaction (RT‐qPCR). We further analyzed the RNA‐seq data by bioinformatics. RESULTS: We identified differentially expressed genes (DEGs) in all five brain regions. The DEGs were significantly enriched in the “dopaminergic synapse” and “retrograde endocannabinoid signaling,” and Gi/o‐GIRK is the shared cascade in the two pathways. We further identified Ephx2, Fam111a, and Gng2 as the potential candidate genes in the pathogenesis of PD for further studies. CONCLUSION: Our study suggested that gene expressions change in the five brain regions following exposure to 6‐OHDA. The “dopaminergic synapse,” “retrograde endocannabinoid signaling,” and Gi/o‐GIRK may be the key pathways and cascade of the synaptic damage in 6‐OHDA PD rats. Ephx2, Fam111a, and Gng2 may play critical roles in the pathogenesis of PD. John Wiley and Sons Inc. 2021-08-04 /pmc/articles/PMC8504527/ /pubmed/34347369 http://dx.doi.org/10.1111/cns.13702 Text en © 2021 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Lyu, Ying
Huang, Yiying
Shi, Guiying
Lei, Xuepei
Li, Keya
Zhou, Ran
Bai, Lin
Qin, Chuan
Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease
title Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease
title_full Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease
title_fullStr Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease
title_full_unstemmed Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease
title_short Transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of Parkinson’s disease
title_sort transcriptome profiling of five brain regions in a 6‐hydroxydopamine rat model of parkinson’s disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504527/
https://www.ncbi.nlm.nih.gov/pubmed/34347369
http://dx.doi.org/10.1111/cns.13702
work_keys_str_mv AT lyuying transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease
AT huangyiying transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease
AT shiguiying transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease
AT leixuepei transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease
AT likeya transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease
AT zhouran transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease
AT bailin transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease
AT qinchuan transcriptomeprofilingoffivebrainregionsina6hydroxydopamineratmodelofparkinsonsdisease